The microtubule-associated protein (MAP) kinase spleen tyrosine kinase (SYK) has also been shown to mediate chemoresistance to PTX in ovarian cancer [184], although the understanding of SYK’s function and action is limited. Here, SYK is linked to ovarian cancer.